Preoperative_and_postoperative_adjuvant_chemotherapy_using_CISCA_(cyclophosphamide,_doxorubicin,_and_cisplatin)_in_the_treatment_of_invasive_transitional-cell_carcinoma_of_the_bladder._Fifteen_patients_with_invasive_(T2-T4)_transitional-cell_carcinoma_of_the_bladder_were_scheduled_for_three_courses_of_CISCA_followed_by_radical_cystectomy_and_two_additional_courses_of_CISCA._Seven_patients_completed_the_entire_protocol,_and_13_completed_all_the_preoperative_courses._Seven_of_13_patients_demonstrated_downstaging_of_their_cancers._Of_these_patients,_one_has_died,_one_is_alive_with_disease,_and_five_are_free_of_disease_at_7_to_38_(mean_17)_months._Of_the_six_patients_without_downstaging,_one_survives_free_of_disease_at_42_months_and_one_is_alive_with_disease_12_months_after_cystectomy._Downstaging_appears_to_be_an_important_prognostic_indicator._Additional_studies_are_being_conducted_to_determine_if_neoadjuvant_chemotherapy_improves_long-term_survival.